# Codex Conference Review: medical_writing_competitor_corpus_production_20260712

Date: 2026-07-12

## Verdict

Pass with Codex corrections. Continue production implementation; do not return to a research-only boundary.

## Boundary Compliance

- All delegated roles were read-only and did not inspect raw PDF text or production data.
- Three independent participants and the exact `aishuo / MiniMax-M3` sole sub-venue reviewer each completed three rounds in one session.
- No provider/model fallback occurred. Codex retained live-source, clinical/regulatory, browser and production-write authority.

## Participant Outputs Reviewed

- `buddy / deepseek-v4-pro`: medical/regulatory translation and approval boundaries.
- `opencode-go / mimo-v2.5`: persistence, secure lifecycle and editor interaction.
- `buddy / glm-5.2`: domain state machine and end-to-end implementation order.

## Hermes Sub-Venue Review

Exact `aishuo / MiniMax-M3` session `20260712_110634_d8a7bf` reconciled the three outputs and explicitly rejected another research-only stopping point. Accepted: glossary pinning, trial-specific admission, visible pending-medical status, version invalidation and a thin two-indication usable path.

## Main-Venue Codex Review

Codex accepts the state-machine direction but corrects three points. The workbench may keep `writing_reference` in its own domain-owned SQLite database because the user explicitly permits modular subsystems with unified APIs; forcing these tables into the already large shared runtime store would increase migration blast radius without product value. Statistical approval is mandatory for statistical/SAP/estimand content, not for every medical prose span. Rights state remains visible and can block approved-corpus admission for the affected document, but it does not stop implementation or prevent pending internal review.

## Codex Independent Verification

Codex inspected the existing editor, AI gateway and runtime persistence. Seven focused suites plus existing medical-writing/contracts regression now pass 58/58 in one run. A live official ClinicalTrials.gov probe caught an invalid field name (`StudyLastUpdatePostDate`) that mocks did not expose; after correction, API v2.0.5 returned data timestamp `2026-07-10T09:00:05`, AD Phase 2 total 453, one requested record and a next-page token. Browser/editor acceptance has not yet run because the evidence drawer is not implemented.

## Final Decision

Authorize continuous implementation. Discovery, medical relevance and validated document-ingest APIs are now in place. Next gates are quarantine/extraction, independent-AI translation, medical review/admission, editor evidence drawer, invalidation and AD/PNH end-to-end browser regression.
